The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania: A potential population for HIV vaccine trials

AIDS

Volumn 14, Issue 3, 2000, Pages 313-320

  Bakari, Mohamed ^a   Lyamuya, Eligius ^a   Mugusi, Ferdinand ^a   Aris, Eric ^a   Chale, Stella ^a   Magao, Paul ^a   Jossiah, Robert ^a   Janabi, Mohamed ^a   Swai, Andrew ^a   Pallangyo, Ndetiyo ^b   Sandström, Eric ^c   Mhalu, Fred ^a   Biberfeld, Gunnel ^d   Pallangyo, Kisali ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b Kilwa Road Police Hospital   (Tanzania)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Africa; Cohort for; HIV 1; Seroincidence; Seroprevalence; Tanzania; Vaccine trials

Indexed keywords

BACTERIUM ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONDOM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; POLICE; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SYPHILIS; TANZANIA; TREPONEMA PALLIDUM;

ADOLESCENT; ADULT; AIDS VACCINES; CLINICAL TRIALS; COHORT STUDIES; DEMOGRAPHY; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HIV-1; HUMANS; INCIDENCE; MALE; POLICE; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SYPHILIS; TANZANIA;

EID: 0034105796     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200002180-00014     Document Type: Article

References (21)

1. 1. UNAIDS Global HIV/AIDS and STD Surveillance. Report on the global HIV/AIDS epidemic, December 1998, Beneva.
2. 2. Tarantola D. Schwartlander B. HIV/AIDS epidemics in sub-Saharan Africa: dynamism, diversity and discrete declines? AIDS 1997, 11(Suppl B):S5-S21.
3. 3. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA Panel. JAMA 1997, 277:1962-1969.
4. 4. Hogg RS, Rhone SA, Yip B, et al. Antiviral effect of double and triple drug combinations amongst HIV-infected adults: lessons from the implementation of viral load-driven antiretroviral therapy. AIDS 1998, 12:279-284.
5. 5. Centers for Disease Control. Zidovudine for the prevention of HIV transmission from mother to infant. MMWR 1994, 43:285-287.
6. 6. Esparza J, Heyward W, Osmanov S. HIV vaccine development: from basic research to human trials. AIDS 1996, 10 (Suppl A):S123-S132.
7. 7. Fast P. Phase I and II trials of candidate HIV-1 vaccines: current status and future directions. In Retroviruses of Human AIDS and Related Animal Diseases, 9th Colloque des 'Cent Gardes'. Edited by Girard M, Valette L. Marnes-La-Coquette, Paris: Foundation Marcel Merrieux; 1994, 293-299.
8. 8. Mulligan MJ, Weber J. Human trials of HIV-1 vaccines. AIDS 1999, 13 (Suppl A):S105-S112.
9. 9. Pahnuphak P, Teeratakulpixarn S, Sarangbin S, et al. International clinical trials of HIV-1 synthetic peptide vaccine in Bangkok, Thailand. Asian Pacific J All Immunol 1997, 15:41-48.
10. 10. WHO Network for HIV Isolation and Characterization. HIV type I variation in World Health Organization sponsored vaccine evaluation sites: genetic screening, sequence analysis and preliminary biological characterization of selected viral strains. AIDS Res Hum Retroviruses 1994, 10:1325-1341.
11. 11. Esparza J, Osmanov S, Kallings LO, Wigzell H. Planning for HIV vaccine trials: the World Health Organization perspective. AIDS 1991, 5 (Suppl 2):S159-S163.
12. 12. WHO Global Programme on AIDS. Proposed criteria for interpretation of results from Western blot assay for HIV-1, HIV-2 and HTLV-II. Wkly Epidemiol Rec 1995, 37:281-283.
13. 13. Centers for Disease Control and Prevention (CDC), USA. A Word Processing, Database and Statistics Program for Public Health. 1994, Atlanta.
14. 14. Nunn AJ, Kengeya-Kayondo JF, Malamba SS, et al. Risk factors for HIV-1 infection in adults in a rural Ugandan community: a population study. AIDS 1994, 8:81-86.
15. 15. Kwesigabo G, Killewo J, Godoy K, et al. Decline in the Prevalence of HIV-1 Infection in Young Women in the Kagera Region of Tanzania. J Acquir Immune Defic Syndr Human Retrovirol 1998, 17:262-268.
16. 16. Hom DL, Johnson JL. Mugyenyi P, et al. HIV-risk and vaccine acceptability in the Ugandan military. J Acquir Immune Defic Syndr Human Retrovirol 1997, 15:375-380.
17. 17. Barongo RL, Borgdoff MW, Mosha FF, et al. The epidemiology of HIV-1 infection in urban, roadside settlements and rural villages in Mwanza region, Tanzania. AIDS 1992, 6:1521-1528.
18. 18. Mnyika KS, Klepp Kl, Kvale G, Nilssen S, Kisila PE, Ole-Kingori N. Prevalence of HIV-1 infection in urban, semi-urban and rural areas in Arusha region, Tanzania. AIDS 1994. 8:1477-1481.
19. 19. Esparza J. Development of WHO-sponsored sites for HIV vaccine evaluation. AIDS Res Hum Retroviruses 1993, 9 (Suppl 1):S133-S134.
20. 20. Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS 1998, 12:75-84.
21. 21. Killewo JZJ, Sandström E, Bredberg-Rådén U, Mhalu FS, Biberfeld G, Wall S. Incidence of HIV-1 infection among adults in the Kagera region of Tanzania. Int J Epidemiol 1993, 22:528-536.